Company ProfilePremium

Mayr-melnhof Karton AG

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Mayr-melnhof Karton AG - Manufacturing & Construction showcase

Year Founded & Workforce

1888

13,080 Employees

Industry

Manufacturing & Construction
Mayr-melnhof Karton AG logo

Mayr-melnhof Karton AG Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Mayr-melnhof Karton AG Overview

MM Group is one of Europe's leading producers of cartonboard and folding cartons, and among the few players that are fully integrated from pulp and board mills to converted packaging. Its Board & Paper division produces about 3.1 million tonnes a year of recycled-fibre and virgin-fibre cartonboard, kraft and uncoated fine papers, and pulp across mills in Austria, Germany, Slovenia, Poland and Finland. Its two packaging divisions convert board into folding cartons for food, confectionery, premium consumer goods and pharmaceuticals; the pharma division also makes leaflets and labels. The group is controlled by the Mayr-Melnhof and allied core families, who hold about 58–60%. It is now in a cost-led transformation called "Fit-For-Future", after a debt-funded expansion in 2021–22 was followed by a structural downturn in European board markets. MM's investment case rests on three things: high-quality packaging franchises with mid-teens adjusted EBITDA margins, a recovery option in a currently sub-scale-margin board business, and a strengthening balance sheet.


What the company does

MM manufactures fibre-based consumer packaging along most of the value chain:

  1. Fibre and board production (MM Board & Paper). The division produces chemical pulp and CTMP in Poland and Finland, recycled-fibre cartonboard (white-lined chipboard, WLC) in Austria, Germany and Slovenia, virgin-fibre folding boxboard (FBB) and solid bleached board (SBB) in Poland and Finland, plus coated liner, uncoated fine paper, kraft papers and market pulp.

    • In FY2025 the division produced 3,138 kt: 1,758 kt cartonboard (incl. coated liner), 505 kt paper and 875 kt pulp, of which 126 kt was market pulp.
  2. Conversion into folding cartons and related printed products (MM Food & Premium Packaging; MM Pharma & Healthcare Packaging). These divisions print, die-cut, emboss, fold and glue cartons for brand owners in food, confectionery, cereals, frozen foods, beverages, tobacco/premium consumer goods, personal care and pharmaceuticals.

    • The pharma division also produces patient leaflets, labels and booklet labels.

    • Packaging output in FY2025 was 2,541 million m² in Food & Premium (2,172 million m² excluding TANN) and 897 million m² in Pharma & Healthcare.

Business and revenue model

Revenue model: Almost entirely product sales. There is no material subscription, licensing or service revenue.

  • Board & Paper sells board and paper by the tonne to independent converters and to MM's own packaging plants. Inter-divisional sales are eliminated on consolidation: segment sales summed to EUR 4,086.9 m against group sales of EUR 3,885.3 m in FY2025, implying about EUR 201.6 m of eliminations (computed from S1).

  • Packaging divisions sell to brand owners under framework and long-term supply contracts. Both packaging divisions announced several new long-term agreements with key customers in H1 2026.

Pricing dynamics: - Board and paper prices are cyclical and set by European supply and demand, import pressure and input costs (wood, recovered paper, energy, chemicals).

  • Packaging pricing is contract-based and generally includes some form of cost pass-through, which makes packaging margins structurally more stable than board margins.

  • This stability is visible in the numbers: the FY2025 adjusted operating margin was 10.2% in Food & Premium versus 0.2% in Board & Paper.

Value-chain position: MM is upstream (pulp/board) plus midstream (converting). Its customers are converters, which are sometimes competitors of its own packaging divisions, and global FMCG and pharma brand owners. MM does not own forests; wood is procured externally. Wood pricing from Polish state forests was cited as uncompetitive in the Kwidzyn context.

Customer types and end markets

End marketServed byNotes
Food (dry, frozen, chilled), cereals, bakeryFPP, B&PCore folding-carton volumes; plastic-to-fibre substitution is an innovation focus
Confectionery, beverages, tea/coffeeFPPPremium print finishing
Premium / luxury consumer goods, cosmeticsFPPLuxury packaging plants, e.g. in France
Tobacco packaging (cigarette cartons)FPPHistorically important. Tipping paper (TANN) was divested in 2025.
Pharmaceuticals and healthcare (cartons, leaflets, labels)PHPGrowth in North America and Ireland; strong demand linked to GLP-1 applications
Independent converters / folding-carton makersB&PMore than 90% of folding boxboard sales volume is in Europe (H1 2026, S2)
Office / graphic papers, packaging kraft paperB&P (Kwidzyn, Kotka)Uncoated fine paper "in sharp decline" in 2025. Packaging kraft paper capacity is being expanded at Kwidzyn.
Market pulpB&P126 kt in FY2025

Company self-description

In its 2026 releases, MM describes itself as a global leader in consumer packaging. It cites cartonboard and folding cartons as its core, complemented by kraft papers, uncoated fine papers, leaflets and labels. Its stated objective is to uphold cost, technology and innovation leadership in cartonboard packaging.

Independent characterisation

MM is best understood as two businesses under one roof:

A high-quality European folding-carton converter: spanning food/premium and pharma. In H1 2026 it delivered a combined adjusted EBITDA of EUR 143.5 m at a 14.3% margin in both packaging divisions.

A cyclical, capital-intensive board and paper producer: It carried EUR 1.85–1.89 bn of capital employed (more than half of group capital employed) but earned a negative to near-zero adjusted ROCE in 2024–H1 2026.

The 2021 acquisitions of Kwidzyn and Kotkamills made MM a major virgin-fibre producer just as European FBB capacity expanded and US exports returned to Europe. That timing explains much of the subsequent profit collapse.

The equity story is therefore one of self-help (Fit-For-Future), portfolio focus (the TANN exit, closures) and optionality on a board-cycle recovery.

Strategy

Stated strategy (themes from the FY2025 and H1 2026 reports)

  1. Cost, technology and innovation leadership in cartonboard packaging, the self-described core.

  2. Portfolio focus on consumer packaging:

    • Exit non-core businesses (TANN, sold because tipping paper is unrelated to cartonboard and consumer packaging).

    • Prune sub-scale plants (Bangor, Leeuwarden, Karaman, Sarreguemines).

    • Make selective core investments (Arnsberg).

  3. Fit-For-Future transformation programme: a group-wide programme for structural earnings improvement.

  4. Balanced three-division positioning: a well-invested asset base and solid financing.

  5. Sustainability as a commercial differentiator:

    • Decarbonisation, water efficiency, biodiversity, waste prevention and occupational safety.

    • CDP triple A; EcoVadis Platinum.

  6. Growth niches:

    • Pharma (US, GLP-1-related applications).

    • Plastic-to-fibre substitution in food packaging.

Fit-For-Future programme: targets and delivery

MilestoneTarget / outcomeSource
Programme launch (2025)More than EUR 150 m earnings uplift by 2027 versus 2024S1
FY2025 results (Mar 2026)More than EUR 250 m uplift in 2027 versus 2024 (excl. TANN and market effects); about EUR 70 m delivered in 2025S1
H1 2026 results (Aug 2026)Target raised to more than EUR 330 m cumulative by 2027 versus 2024 excl. TANN; EUR 105 m delivered in H1 2026; more than EUR 100 m expected in H2 2026S2
One-off costsEUR 29.0 m (FY2025); EUR 22.9 m (H1 2026)S1, S2

Strategic initiatives in the last 24 months

InitiativeDateDetailSource
Sale of TANN GroupAgreed Dec 2024; closed Jun 2025EUR 360 m EV; about EUR 220 m sales; EUR 125.1 m gainS1, S10
Share buybackJan–Dec 2025569,019 shares, EUR 41.2 mS11
New dividend policyMar 2026Payout of 40–60% of profit, subject to leverage corridors, capex needs and dividend continuity (previously one-third of profit)S1
Kwidzyn efficiency packageCompletion autumn 2026About EUR 100 m: continuous pulp digester (lower energy use, CO2 and wood cost), winder and transport modernisation, new sheeter. About EUR 30 m annual earnings contribution from 2027. CO2 at the mill to fall by about one-third.S1, S2
Kotka electric boilersSpring 2027Significant CO2 reductionS1
Romania packaging expansionCommercial production Oct 2026Capacity for new business onboardingS1, S2
US pharma expansionContribution from 2027Growth capexS2
PHP South-West Europe restructuring2,025EUR 15.2 m footprint charges (France, Spain)S1
Arnsberg acquisitionSigned Aug 2026; closing Q4 2026230 kt recycled board; turnaround via synergiesS7
Reporting streamliningFrom Q1 2026Q1 and Q3 reported as trading statements onlyS6
Management Board expansionSep 2026Five members, adding divisional headsS8

Guidance and medium-term framework

2026 outlook:

  • Challenging business environment, with subdued consumer demand and higher transport, energy, chemical, wood and recovered-paper costs.

  • Q3 2026 maintenance standstills at Kwidzyn and Kotka (about EUR 35 m impact).

  • Partial offsets: slightly improved prices for selected board and paper grades, continued growth in selected pharma and consumer applications, and more than EUR 100 m of Fit-For-Future contribution in H2.

Capex: about EUR 250 m in 2026.

Financial framework: net debt/equity 35–55% and net debt/adjusted EBITDA 1.5–2.5x.

Explicit numeric EBITDA, EPS or margin guidance for 2026: not provided.

Products & Services

MM does not publish list prices. Pricing is negotiated per tonne for board and per contract for cartons. MM's releases do not give launch years for most individual grades. Brand names below are given where verified; others are marked.

MM Board & Paper

Product lineDescription / specificationsTarget customerProduction baseNotes
Recycled-fibre cartonboard (WLC / GD/GT grades), incl. TOPCOLOR®Coated recycled board for folding cartons. TOPCOLOR is an MM recycled-board brand (pictured in Aug 2026 trade coverage).Folding-carton converters; food, household and non-food packagingFrohnleiten (AT), Neuss (DE), Gernsbach (DE), Kolicevo (SI)Market "relatively resilient" in 2025–H1 2026. Arnsberg (DE, about 230 kt, liner focus) to be added from Q4 2026.
Coated liner (recycled)Liner products for laminated / corrugated applicationsCorrugated and laminating convertersRecycled mills; Arnsberg specialises in linerIncluded in cartonboard tonnage
Virgin-fibre folding boxboard (FBB)Lightweight, high-bulk primary-fibre board for food, pharma and premium packagingBrand owners and converters requiring primary fibreMM Kwidzyn (PL), MM Kotkamills (FI)Under pressure from new European capacity, returning US exports and Asian imports
Solid bleached board (SBB)Premium bleached boardPremium / luxury and pharma packagingKotkamills / KwidzynIncluded in folding-carton board tonnage (S2 footnote)
Food-service and barrier boards (Kotkamills legacy portfolio)Cup / food-service board and dispersion-barrier boards for plastic replacementFood-service and cup convertersKotka (FI)Specific brand names (e.g. ISLA, AEGLE) are not re-verified for current MM branding
Uncoated fine paper (UFP)Office, copy and graphic papers in reels and cut-sizePaper merchants, offices, printersKwidzyn (PL)Market "in sharp decline" in 2025. A new sheeter and modernised winders are increasing reel-format flexibility.
Packaging kraft paper (PKP)Kraft paper for flexible and paper packagingPackaging convertersKwidzyn (PL); Kotka (FI)Capacity and flexibility increased via the 2026 Kwidzyn projects. Sack kraft was discontinued at Kwidzyn.
Saturating / absorbent kraft (Kotkamills legacy)Kraft for decorative laminatesLaminate producersKotka (FI)—
Market pulpChemical pulp and CTMP not used internallyPaper and board producersKwidzyn, Kotka126 kt in FY2025; 45 kt in H1 2026
MetricFY2024FY2025
Cartonboard incl. coated liner (kt)1,7631,758
Paper (kt)497505
Pulp total (kt)885875
Market pulp (kt)119126
Total tonnage produced (kt)3,1453,138

Volume profile (kt produced):

Source: S1. H1 2026 tonnage was 1,645 kt, of which 936 kt folding-carton board, 262 kt paper and 447 kt pulp.

MM Food & Premium Packaging

OfferingDescriptionTarget customerNotes
Food folding cartonsPrinted and converted cartons for dry, chilled and frozen foods, cereals and bakeryGlobal and regional FMCG brand ownersLargest volume line. Innovation focus on replacing plastic with fibre-based alternatives.
Confectionery and beverage packagingHigh-graphics cartons, multipacks, gift boxesConfectionery and beverage brandsPremium finishing (embossing, hot-foil, special coatings)
Premium / luxury packagingRigid and folding luxury boxes for cosmetics, spirits and fragrancesLuxury brand housesLuxury packaging plants in France
Tobacco packagingCigarette cartons and inner framesTobacco majorsLong-standing franchise. Tipping paper (TANN; about EUR 220 m sales, 7 sites, about 730 staff) was sold in 2025.
Personal-care and household cartonsFolding cartons for HPC productsHPC brand owners—
MetricFY2024FY2025
FPP produced volume incl. TANN (million m2)3,1032,541
FPP produced volume excl. TANN (million m2)2,2402,172

Volume (million m², produced):

Source: S1.

Capacity actions:

  • Technological expansion of the Romania plant, with commercial production scheduled from October 2026.

  • Superpak Karaman (Turkey) closed, with business concentrated at the remaining two Turkish plants.

  • Bangor (UK) and Leeuwarden (NL) sold.

  • Two plants in the Middle East contributed about 2% of group sales and about 6% of group adjusted EBITDA in 2025. MM warned of expected business interruptions in March 2026.

MM Pharma & Healthcare Packaging

OfferingDescriptionTarget customerNotes
Pharma folding cartonsSecondary packaging with serialisation and tamper-evidence featuresBig pharma, generics, OTC, CDMOsGLP-1 related demand supported H1 2026 growth
Patient information leafletsFolded leaflets, high-speed multi-panelPharma manufacturersFrench leaflet plants include L'Isle d'Espagnac and Soyaux. Sarreguemines (523 m units/yr) closed.
Labels and booklet labelsPressure-sensitive and multi-page labelsPharma and healthcarePart of the Essentra Packaging heritage
Healthcare / consumer health packagingCartons for medical devices and consumer healthHealthcare companies—

Volume: 918 million m² in FY2024 and 897 million m² in FY2025. H1 2026: 470 million m², up 1.1%.

Growth investments: Expansion investments in the US are on schedule and expected to contribute from 2027.

Financial Narrative

Income statement

Basis and sources:

  • FY2021–22: S5. FY2023: S4. FY2024: S3. FY2025: S1.

  • "EBITDA, headline basis" is reported EBITDA for FY2021–22 and adjusted EBITDA for FY2023–25 (FY2024 reported equals adjusted).

  • FY2025 reported EBITDA was EUR 517.0 m, including the TANN gain.

  • FY2021 revenue growth is computed from the 2020 sales of EUR 2,528 m (aggregator, S17).

  • Diluted EPS equals basic EPS. No dilutive instruments were disclosed in the reviewed releases.

Adjusted series (company definition):

Sources: S1, S3, S4.

Margins (reported basis, computed):

Gross profit: MM's results releases do not report gross profit. Aggregator-derived gross figures are inconsistent across providers, so gross profit and gross margin are treated as not publicly disclosed in the reviewed primary sources.

Revenue CAGR (computed):

  • FY2021–FY2025: +6.1% a year, driven entirely by the 2021–22 acquisitions.

  • FY2022–FY2025: -6.0% a year, reflecting price deflation in board and the TANN disposal.

Below operating profit, FY2025:

  • Financial income: EUR 16.5 m (FY2024: EUR 27.1 m).

  • Financial expenses: EUR -53.4 m (FY2024: EUR -82.9 m).

  • Other financial result: EUR -38.5 m (FY2024: EUR -19.9 m), mainly FX.

  • Tax: EUR -68.7 m, an effective rate of 47.2%, driven by reversal of capitalised loss carryforwards at Board & Paper (FY2024: 3.4%, flattered by capitalisation of former Essentra loss carryforwards).

Quarterly trajectory

H1 2026 group results:

  • Sales: EUR 1,849.3 m (pro forma -4.7%).

  • Adjusted EBITDA: EUR 200.2 m (pro forma -3.5%, +6.6% versus H2 2025).

  • Reported operating profit: EUR 66.9 m, after EUR 22.9 m of Fit-For-Future one-offs.

  • Profit for the period: EUR 31.2 m. EPS: EUR 1.60.

  • Operating cash flow: EUR 145.1 m. Free cash flow: EUR 37.0 m. Capex: EUR 111.8 m.

  • Effective tax rate: 32.0%.

Balance sheet

Sources: S5 (FY2021–22) and S1 (FY2024–25).

Sources: S1, S3, S4, S5.

Other balance-sheet items:

Source: S1. The FY2024 figures include TANN cash and financial liabilities; balance-sheet values after reclassification were EUR 1,628.7 m and EUR 520.9 m.

Short-/long-term debt split: described only as "mainly long-term". The exact split is not publicly disclosed in the reviewed releases.

  • The aggregator tangible book value per share fell sharply after the 2021–22 acquisitions, indicating material goodwill.

Working capital: a working-capital increase drove the FY2025 drop in operating cash flow. An absolute net working capital figure is not publicly disclosed in the reviewed releases.

Cash flow

Sources: S1, S3, S4, S5. The FY2022 D&A figure includes impairments.

Shareholder returns:

  • Share buybacks: zero in FY2021–24 (no programme disclosed). FY2025: EUR 41.2 m (569,019 shares).

  • Total cash dividends paid: not separately retrieved. DPS is shown in 6.1.

Guidance and planned spend:

  • 2026 capex guided at about EUR 250 m.

  • Annual maintenance standstills cost about EUR 36 m in 2025 and about EUR 40 m guided for 2026, of which about EUR 35 m falls in Q3 2026.

Ratios

Ratio notes:

  • FY2021–22 ROCE is reported ROCE; FY2024–25 is adjusted ROCE. ROE for FY2021–22 and FY2024–25 is company-reported. ROA, asset turnover and net debt/equity are computed.

  • Net debt/equity was reported at 0.6 and net debt/EBITDA at 2.8.

  • Interest coverage, operating profit / financial expenses (computed):

    • FY2024: 2.3x (190.0 / 82.9).

    • FY2025: 4.1x reported (221.0 / 53.4) or 3.7x adjusted (195.4 / 53.4).

  • Debt/equity, financial liabilities / equity (computed): 0.77x in FY2024 and 0.67x in FY2025.

  • Current ratio: about 1.8x on aggregator balance-sheet data (current assets EUR 1.48 bn / current liabilities EUR 0.83 bn, S17).

  • Cash conversion cycle: not publicly disclosed.

  • Dividend-policy leverage corridors: net debt/equity 35–55% and net debt/adjusted EBITDA 1.5–2.5x. At end-2025 MM was at 43% and 2.2x.

Commentary on trends, inflections and drivers

FY2021–22: acquisition-led step change.

  • Kwidzyn and Kotkamills (consolidated from August 2021) and Essentra Packaging (from late 2022) lifted sales 52.5% in FY2022.

  • A tight board market and price pass-through of an energy shock pushed reported EBITDA to EUR 729.9 m and operating profit to EUR 510.3 m.

  • Net debt rose to EUR 1,481.5 m, financed largely through Schuldschein loans.

  • This was peak earnings.

FY2023: cyclical collapse.

  • Destocking and falling board prices cut adjusted EBITDA 41.5% to EUR 450.2 m. Net profit fell 74% to EUR 89.1 m.

  • Management responded with a profit and cash protection plan focused on working-capital release and capex restraint.

  • The result was record operating cash flow of EUR 786.2 m and free cash flow of EUR 369.8 m, which cut net debt to EUR 1,261.9 m. This was the first deleveraging inflection.

FY2024: trough-level margins, continued deleveraging.

  • Adjusted EBITDA fell a further 7% to EUR 418.5 m. Board & Paper posted an adjusted operating loss of EUR 19.2 m.

  • Strong Q4 cash generation reduced net debt to EUR 1,078.7 m.

FY2025: portfolio and cost reset.

  • The TANN sale (EUR 360 m EV) removed a high-margin but non-core business. Group adjusted EBITDA was flat at EUR 418.2 m, but pro forma it grew 7.9%, driven by Fit-For-Future savings (about EUR 70 m) and the Board & Paper turnaround to breakeven.

  • Reported net profit fell to EUR 77.0 m because of the Kolicevo impairment and a 47% tax rate.

  • Free cash flow almost disappeared (EUR 11.1 m) on working-capital outflows.

H1 2026: earnings stabilise, cash recovers.

  • Pro forma adjusted EBITDA (EUR 200.2 m) was almost flat year on year despite lower board prices and Middle East-related cost inflation.

  • Operating cash flow swung from EUR -103.3 m to EUR +145.1 m.

  • The key inflection to watch is whether Fit-For-Future (more than EUR 330 m cumulative by 2027) can outrun price deflation in board.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Division Overview

DivisionBoard responsibility (from 1 Sep 2026)Contents

MM Food & Premium Packaging (FPP)

Roman Billiani

Folding cartons for food, confectionery, cereals, frozen foods, beverages, premium/luxury consumer goods and tobacco. Included TANN tipping paper until 2 Jun 2025.

MM Pharma & Healthcare Packaging (PHP)

Andreas Koppitz

Pharma folding cartons, leaflets, labels and booklet labels. Sites in Western Europe (France, Spain, Ireland, Italy, UK, Nordics, etc.) and the US.

MM Board & Paper (B&P)

Alexander Loimayr

Recycled-fibre cartonboard (WLC), virgin-fibre FBB/SBB, coated liner, uncoated fine paper, kraft papers, chemical pulp and CTMP

Revenue by Segment

SegmentFY2024FY2025

Food & Premium Packaging sales (EUR Mn)

1,702.41,538.4

Food & Premium Packaging excl. TANN sales (EUR Mn)

1,488.71,449.7

Pharma & Healthcare Packaging sales (EUR Mn)

615.7618.3

Board & Paper sales (EUR Mn)

1,954.31,930.2

Group consolidated sales (EUR Mn)

4,079.63,885.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment and Segment Margins & Growth (%)

MetricFY2024FY2025

FPP adjusted EBITDA (EUR Mn)

258.3228.2

FPP adjusted operating profit (EUR Mn)

179.4157.3

FPP adjusted operating margin (%)

10.510.2

FPP excl. TANN adjusted EBITDA (EUR Mn)

206.2205.4

FPP excl. TANN adjusted operating profit (EUR Mn)

139.4134.5

PHP adjusted EBITDA (EUR Mn)

69.977.7

PHP adjusted operating profit (EUR Mn)

29.837.2

PHP adjusted operating margin (%)

4.86.0

B&P adjusted EBITDA (EUR Mn)

90.3115.0

B&P adjusted operating profit (EUR Mn)

-19.23.4

B&P adjusted operating margin (%)

-1.00.2

Division Overview — FPP

DivisionSales YoY %Adj. EBITDA YoY %Share of group sales (gross, %)Adj. ROCE %Capital employed EUR MnCapex EUR Mn

FPP (reported)

-9.6-11.639.615.41,018.868.1

FPP excl. TANN

-2.6-0.437.314.3937.464.4

PHP

+0.4+11.215.98.3449.944.2

B&P

-1.2+27.249.70.21,888.7123.1

Revenue by Segment and Segment Margins & Growth (%)

MetricH1 2025H2 2025H1 2026

FPP excl. TANN sales (EUR Mn)

724.6725.1684.0

FPP excl. TANN adjusted EBITDA (EUR Mn)

97.0108.497.9

FPP excl. TANN adjusted EBITDA margin (%)

13.414.914.3

PHP sales (EUR Mn)

320.8297.5318.8

PHP adjusted EBITDA (EUR Mn)

40.137.645.6

PHP adjusted EBITDA margin (%)

12.512.714.3

B&P sales (EUR Mn)

1,000.1930.1940.4

B&P adjusted EBITDA (EUR Mn)

70.344.756.8

B&P adjusted EBITDA margin (%)

7.04.86.0

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (EUR Mn)

3,069.74,682.14,164.44,079.63,885.3

Revenue growth YoY (%)

21.452.5-11.1-2.0-4.8

EBITDA, headline basis (EUR Mn)

421.0729.9450.2418.5418.2

Operating profit, reported (EUR Mn)

269.6510.3197.6190.0221.0

Profit before tax (EUR Mn)

244.5466.9136.7114.3145.7

Net profit / profit for the year (EUR Mn)

190.7345.289.1110.577.0

EPS basic (EUR)

9.4617.194.365.413.86

Dividend per share (EUR)

3.504.201.501.802.00

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%) (FY2022–FY2025)

MetricFY2022FY2023FY2024FY2025

Adjusted EBITDA (EUR Mn)

769.0450.2418.5418.2

Adjusted operating profit (EUR Mn)

562.4229.2190.0195.4

Adjusted EBITDA margin (%)

16.410.810.310.8

Adjusted operating margin (%)

12.05.54.75.0

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

EBITDA margin, headline basis (%)

13.715.610.810.310.8

Operating margin, reported (%)

8.810.94.74.75.7

Net margin (%)

6.27.42.12.72.0

Income Statement and Margin Analysis (%) (FY2024–FY2025)

MetricFY2024FY2025

Sales excl. TANN (EUR Mn)

3,866.03,796.6

Adjusted EBITDA excl. TANN (EUR Mn)

366.5395.4

Adjusted operating profit excl. TANN (EUR Mn)

150.1172.5

Adjusted EBITDA margin excl. TANN (%)

9.510.4

Financial Analysis

ItemOperating profit, EUR MnEBITDA, EUR Mn

Gain on sale of TANN Group (FPP)

+125.1+125.1

Impairment MM Kolicevo (B&P)

-70.5—

Fit-For-Future restructurings: PHP footprint optimisation

-15.2-13.6

Fit-For-Future restructurings: other

-13.8-12.7

Net one-offs

+25.6+98.8

Income Statement and Margin Analysis (%) (Quarterly)

MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Group sales (EUR Mn)

1,042.6987.4949.5905.8927.5921.8

Group adjusted EBITDA (EUR Mn)

119.3111.289.897.9104.196.1

Group adjusted operating profit (EUR Mn)

61.055.735.243.549.140.7

Group adjusted EBITDA margin (%)

11.411.39.510.811.210.4

Pro forma excl. TANN adjusted EBITDA (EUR Mn)

104.8102.690.098.0104.196.1

Balance Sheet and Margin Analysis (%)

MetricFY2021FY2022FY2024FY2025

Total assets (EUR Mn)

4,014.24,818.64,863.14,477.8

Total equity (EUR Mn)

1,661.91,959.42,128.72,103.6

Equity ratio (%)

41.440.743.847.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Financials and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

Net debt (EUR Mn)

1,063.51,481.51,261.91,078.7913.7

Net debt / EBITDA, company basis (x)

2.12.02.82.62.2

Balance Sheet

ItemFY2024FY2025

Financial liabilities (mainly long-term), EUR Mn

1,631.11,412.1

Cash available, EUR Mn

552.4498.4

Undrawn committed credit lines, EUR Mn

361.0351.3

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (EUR Mn)

269.8299.7786.2516.3231.1

Cash Flow (FY2022–FY2025)

MetricFY2022FY2023FY2024FY2025

Free cash flow, company definition (EUR Mn)

-19.7369.8302.211.1

Cash Flow — Capital expenditures

MetricFY2021FY2022FY2024FY2025

Capital expenditures (EUR Mn)

257.8345.1220.9232.7

Depreciation and amortisation (EUR Mn)

151.4219.6228.0219.7

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2024FY2025

ROE, company (%)

11.919.15.33.6

ROA, net profit / total assets (%)

4.87.22.31.7

Asset turnover (x)

0.760.970.840.87

Net debt / equity (x)

0.640.760.510.43

Returns & Leverage Ratios (%)

MetricFY2021FY2022FY2024FY2025

ROCE / adjusted ROCE (%)

12.816.35.65.8

Geographic Revenue

IndicatorValueSource

Share of B&P folding-carton board sales volume in Europe

More than 90% (H1 2026); overseas business deliberately reduced

S2

Middle East packaging plants, share of group sales (FY2025)

About 2%

S1

Middle East packaging plants, share of group adjusted EBITDA (FY2025)

About 6%

S1

PHP growth regions (H1 2026)

North America and Ireland, versus subdued individual Western/Central European markets

S2

PHP growth region (FY2025)

Solid growth in the United States

S1

TANN sites divested (2025)

Austria, China, the Philippines, Turkey, Canada, Germany

S10

Margin Analysis (%) (FY2022–FY2025)

MetricFY2022FY2023FY2024FY2025

Annual share price performance (%)

-12.99-17.44-37.2017.71

Share Price & Returns

Horizon (as of 15 Jan 2026, price EUR 92.70)Performance

1 year

+22.6%

3 years

-40.1%

5 years

-44.1%

10 years

-11.4%

Valuation Multiples

MultipleBasisValue

Market capitalisation

EUR 82 × 19.43 m

About EUR 1.59 bn

Enterprise value

Market cap + FY2025 net debt (EUR 913.7 m); minorities, leases and pensions ignored

About EUR 2.51 bn

P/E

FY2025 EPS EUR 3.86

About 21x (aggregators show 20–22x, S17)

EV / adjusted EBITDA

FY2025 adjusted EBITDA EUR 418.2 m

About 6.0x

EV / sales

FY2025 sales EUR 3,885.3 m

About 0.65x

P/B

FY2025 equity EUR 2,103.6 m

About 0.76x (aggregators: about 0.72x, S17)

Dividend yield

DPS EUR 2.00

About 2.4%

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (EUR)

3.504.201.501.802.00

Payout ratio (DPS / EPS, %)

37.024.434.433.351.8

Capital Programmes

ProgrammeAuthorisationExecutedAverage priceValue

3 Jan – 23 Dec 2025

AGM 24 Apr 2024 (Section 65(1) no. 8 Austrian Stock Corporation Act). Up to 1 m shares (5%); price range EUR 10–80.

569,019 shares (2.85%)

EUR 72.45

EUR 41.2 m

Analyst Conclusions

Management guidance (latest, 20 Aug 2026; S2)

H2 2026 environment: continued difficult conditions, with subdued consumer demand and higher transport, energy, chemical, wood and recovered-paper costs.

Q3 2026: operating profit burdened by about EUR 35 m of maintenance standstills at Kwidzyn and Kotkamills.

Offsets: slightly better pricing for selected board and paper grades, continued growth in selected pharma and consumer applications, and more than EUR 100 m of Fit-For-Future contribution in H2.

Fit-For-Future: more than EUR 330 m cumulative uplift by 2027 versus 2024 (excl. TANN).

Investment contributions: Kwidzyn, Romania and US projects contribute from 2027. Arnsberg synergies follow after closing.

Capex: about EUR 250 m in 2026.

Consensus growth expectations

Aggregators indicate an expected revenue CAGR of about 1–2% over the next three years (alphaspread, Simply Wall St, S17). Price targets cluster around EUR 90–98.

Bull case

  1. Self-help compounds.

    • Fit-For-Future is running well ahead of plan: EUR 175 m delivered by mid-2026, and the target was raised twice to more than EUR 330 m.

    • The Kwidzyn projects (about EUR 30 m a year) and Arnsberg synergies add further from 2027.

    • On a flat market, this could lift adjusted EBITDA well above the EUR 418 m FY2025 level.

  2. Board & Paper has operating leverage to any price recovery.

    • Utilisation is at 87%, the order backlog is up to 195 kt, and European market-share gains have been made.

    • Each 1 percentage point of margin on about EUR 1.9 bn of sales is worth about EUR 19 m.

    • The division's EUR 1.85 bn capital base is in the valuation at below book (P/B about 0.75x).

  3. The packaging franchises are under-appreciated.

    • FPP (excl. TANN) and PHP both generate about 14% EBITDA margins.

    • PHP is now growing profitably in the US, helped by GLP-1-related demand.

    • The new 40–60% payout policy and a 2.2x leverage ratio support rising distributions.

Bear case

  1. Structural, not cyclical.

    • European FBB overcapacity, returning US exports, Asian imports and declining office paper may keep B&P returns near zero indefinitely.

    • The adjusted ROCE of -0.5% LTM and the EUR 70.5 m Kolicevo impairment suggest further write-downs or closures are possible.

  2. Cost and geopolitical shocks.

    • The Middle East escalation affects plants that provide about 6% of adjusted EBITDA and inflates energy, transport and chemical costs.

    • Management itself warns of "earnings risks" in an industry with structural overcapacity.

  3. Cash conversion and earnings quality.

    • FY2025 free cash flow was only EUR 11.1 m. Reported net profit (EUR 77 m) was below the dividend-plus-buyback capacity implied by policy.

    • Recurring "one-off" restructuring charges (EUR 29 m in 2025, EUR 22.9 m in H1 2026) and volatile tax rates blur the true earnings base.

    • FPP volumes are falling (-7.1% in H1 2026).

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
5 Nov 2026Q3 2026 trading statement: size of the standstill impact, B&P pricing, Fit-For-Future run-rate
Q4 2026Closing of the Arnsberg acquisition; disclosure of price and synergies
Q4 2026Completion of the Kwidzyn digester; Romania expansion ramp-up
Q4 2026 – H1 2027European board price announcements (FBB and WLC)
OngoingMiddle East plant operations and energy prices
Mar 2027FY2026 results: dividend under the new payout policy; possible further impairments; 2027 Fit-For-Future update
Spring 2027Kotka electric boilers commissioned
2,027US pharma expansion contribution; any new buyback

Analyst verdict

Mayr-Melnhof is a company in the middle of a credible but incomplete repair. The 2021–22 bet on virgin-fibre board (Kwidzyn, Kotkamills) was made at the top of the cycle. Since then the European board market has moved into structural oversupply, driving group adjusted EBITDA from EUR 769 m (FY2022) to about EUR 418 m (FY2024–25), with the board division earning roughly nothing on more than EUR 1.8 bn of capital.

What has changed in the past 18 months is management's response:

  • a decisive portfolio clean-up (the TANN sale at EUR 360 m EV, five plant exits);

  • a transformation programme that is visibly over-delivering, with EUR 175 m booked by mid-2026 against a target raised twice to more than EUR 330 m;

  • continued deleveraging, with net debt down to EUR 914 m and 2.2x EBITDA;

  • a more shareholder-friendly dividend framework.

The two packaging divisions, with about 14% EBITDA margins and FPP's mid-teens ROCE, are genuinely good businesses and would probably command higher multiples on a standalone basis.

Against this, the market is right to be sceptical about how much of the Fit-For-Future gain will reach the bottom line rather than being absorbed by price deflation in board and by cost shocks from the Middle East. H1 2026 showed exactly this: adjusted EBITDA fell slightly despite EUR 105 m of savings. Weak 2025 cash conversion and recurring restructuring charges also temper the quality of earnings.

At about 6x EV/adjusted EBITDA and about 0.75x book, the valuation already discounts a prolonged board trough. Upside requires either evidence that savings are translating into EBITDA growth from H2 2026, or a turn in board pricing. The Q3 2026 trading statement and the FY2026 results will be the decisive tests.

Overall stance: constructive but conditional. This is a self-help and recovery story with a valuation floor provided by the packaging franchises and the balance sheet. Conviction would rise materially on sustained B&P margin improvement and on free cash flow covering the dividend.


Market data from aggregators are indicative only. This document does not constitute investment advice.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleBoard tenureAgeBackground (verified)

Peter Oswald

Chairman of the Management Board and CEO

Since 2020; reappointed to 31 May 2029

61 in Mar 2024

Long-standing paper and packaging executive, formerly at Mondi. Responsible for Board & Paper on an interim basis from Dec 2024 until mid-2025.

Franz Hiesinger

CFO

Since Oct 2017; reappointed 1 Oct 2025 – 30 Sep 2030

58 in Mar 2024

Previously held senior MM roles in group reporting, accounting, risk management and legal/compliance/internal audit (S17 profile).

Roman Billiani

Member; Food & Premium Packaging

Since 1 May 2024; term to 30 Apr 2027

50 in Mar 2024

About 20 years in fibre-based packaging management. Previously Managing Director "Food & Specialities Packaging" in MM Packaging.

Andreas Koppitz

Member; Pharma & Healthcare Packaging

Since 1 Sep 2026; 3-year term

46

Has led the Pharma & Healthcare Packaging division since 2022

Alexander Loimayr

Member; Board & Paper

Since 1 Sep 2026; 3-year term

47

Has led Board & Paper since mid-2025.

Board & Management Changes

DateChangeContext

Mar 2024

Oswald reappointed; Billiani added

Continuity during transformation

11 Nov 2024

Niels Flierman (ex-DS Smith Paper & Recycling head) appointed for B&P from Jan 2025

Intended to strengthen board-mill turnaround expertise

23 Dec 2024

Flierman withdraws for personal reasons; Oswald covers B&P

Leadership gap at the weakest division

May 2025

Hiesinger reappointed to 2030

Financial continuity

Mid-2025

Loimayr takes over B&P division leadership

Internal appointment

27 Aug 2026

Board expanded to five (Koppitz, Loimayr)

Response to group size and complexity; divisional heads given Board seats

Major Shareholders

HolderStake %

FMR LLC (Fidelity)

5.22

Erste Asset Management

2.93

Capital Research and Management

1.24

Massachusetts Financial Services

0.76

Lazard Frères Gestion

0.65

Norges Bank Investment Management

0.55

Dimensional Fund Advisors

0.54

Charles Schwab Investment Management

0.21

Universal Investment

0.18

Raiffeisen Kapitalanlage-Gesellschaft

0.14

Competitive Landscape

Competitors by Segment

SegmentCompetitorPositioning versus MM

Recycled cartonboard (WLC)

Reno De Medici (R.D.M., Apollo-owned)

Europe's other major recycled-board producer. MM is buying RDM's Arnsberg operations.

Recycled cartonboard (WLC)

Smurfit Westrock (European board mills)

Diversified paper-based packaging major

Recycled cartonboard (WLC)

Various Iberian, Italian and German mid-sized mills

Fragmented capacity contributing to overcapacity

Virgin-fibre FBB / SBB

Metsä Board (Finland)

Leading European FBB producer; directly exposed to the same import and capacity pressures

Virgin-fibre FBB / SBB

Stora Enso (Packaging Materials)

Large Nordic board producer; added FBB capacity

Virgin-fibre FBB / SBB

Holmen Iggesund

Premium SBB/FBB

Virgin-fibre FBB / SBB

Graphic Packaging International (US)

US paperboard exporter; MM cites the return of US export volumes to Europe as a pressure factor

Virgin-fibre FBB / SBB

Asian producers (e.g. Chinese FBB mills)

Rising import pressure

Uncoated fine paper

Sylvamo, Mondi, The Navigator Company

MM's Kwidzyn UFP competes in a structurally declining market

Food & premium folding cartons

Graphic Packaging International (incl. former AR Packaging Europe)

Largest folding-carton converter in Europe and the US

Food & premium folding cartons

Smurfit Westrock (consumer packaging)

Integrated competitor

Food & premium folding cartons

Van Genechten Packaging; Edelmann (consumer); regional independents

European mid-sized converters

Pharma & healthcare packaging

August Faller

Pharma cartons, leaflets, labels

Pharma & healthcare packaging

Edelmann Group

Pharma and healthcare packaging

Pharma & healthcare packaging

Schreiner MediPharm; Körber (pharma packaging solutions)

Labels and pharma packaging technology

Pharma & healthcare packaging

Regional printers (Western Europe and US)

Contributing to the intense competition MM cites in Western/Central Europe

Peer Comparison FY2025

CompanyLatest FY revenueGrowth trendMargin profile

Mayr-Melnhof (FY2025)

EUR 3,885.3 m

-4.8% (pro forma -1.8%)

Adjusted EBITDA margin 10.8%; adjusted operating margin 5.0%

Metsä Board

—

Under pressure from FBB overcapacity

—

Smurfit Westrock

—

Merger-driven

—

Recent Developments

Litigation, regulatory actions and large layoffs in the window: none material identified beyond the restructurings listed above.

Company Snapshot

$4,380.3M

Revenue

13,080

Employees

1888

Founded

Vienna, Austria

Headquarters

SWOT Analysis

Strengths

  • Resilient packaging margins. FPP (excl. TANN) and PHP each delivered a 14.3% adjusted EBITDA margin in H1 2026.
  • Strong ROCE in Food & Premium Packaging: adjusted ROCE of 15.1% (LTM, H1 2026) excluding TANN.
  • Deleveraging track record. Net debt fell from EUR 1,481.5 m (FY2022) to EUR 913.7 m (FY2025), and net debt/adjusted EBITDA from 2.8x (FY2023) to 2.2x.
  • Self-help delivery. Fit-For-Future delivered EUR 70 m in 2025 and EUR 105 m in H1 2026; the target has been raised twice, from more than EUR 150 m to more than EUR 250 m and then more than EUR 330 m.
  • Liquidity. EUR 498.4 m cash plus EUR 351.3 m undrawn facilities at end-2025.
  • ESG leadership. CDP triple A, EcoVadis Platinum 91/100 and an 11% cut in absolute Scope 1+2 emissions in 2025.
  • Integration. About 3.1 Mt of board, paper and pulp production underpins the packaging supply chain.

Weaknesses

  • Board & Paper earns almost nothing on large capital. Adjusted ROCE was -0.5% (LTM, H1 2026) on EUR 1,846.9 m of capital employed.
  • Low group returns: adjusted ROCE of 5.3% (LTM, H1 2026). ROE was 3.6% in FY2025.
  • Weak FY2025 cash conversion. FCF was EUR 11.1 m, against EUR 302.2 m in FY2024.
  • Repeated asset write-downs and closures: Kolicevo EUR 70.5 m (2025), Hirschwang (2020), Bielefeld (2022), Cervia (2023).
  • Tax volatility. The effective tax rate swung from 3.4% (2024) to 47.2% (2025) on loss-carryforward accounting.
  • Leadership turnover at B&P. The designated division head withdrew in Dec 2024, leaving a six-month interim period.

Opportunities

  • Arnsberg (230 kt) adds recycled-board and liner capacity with synergy potential in the German network.
  • Kwidzyn projects worth about EUR 100 m are expected to add about EUR 30 m a year from 2027 and cut mill CO2 by about one-third.
  • US pharma expansion and GLP-1-related demand, which supported PHP adjusted EBITDA growth of 14% in H1 2026.
  • Plastic-to-fibre substitution in food packaging.
  • Board price recovery. Every percentage point of B&P margin on about EUR 1.9 bn of sales is worth about EUR 19 m of EBIT (computed from S1).
  • Higher payout ratio. The new 40–60% policy could raise dividends materially as earnings recover.

Threats

  • Persistent overcapacity and import pressure in European virgin-fibre board.
  • Middle East escalation: plant interruptions and a cost shock to energy, transport and chemicals from March 2026.
  • Continued decline in uncoated fine paper.
  • Consumer weakness in Europe reducing folding-carton volumes. FPP produced volume fell 7.1% in H1 2026.
  • Intense competition in Western/Central European pharma packaging.
  • Input costs. Wood, recovered paper and energy are expected to rise in H2 2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
29 Apr 2025Q1 2025 results: sales EUR 1,042.6 m (+1.7%), adjusted EBITDA EUR 119.3 m (+26.2%), net profit EUR 21.1 m. A major fire at a Polish FPP plant weighed slightly on volumes.Strong start to Fit-For-Future
May 2025CFO Franz Hiesinger reappointed to Sep 2030Finance continuity
2 Jun 2025TANN sale closed (EUR 360 m EV)Deleveraging and portfolio focus
Mid-2025Alexander Loimayr assumes leadership of Board & PaperFills the gap left by Flierman's withdrawal
2025 (H1)PHP footprint optimisation in France and Spain; Sarreguemines closureTurnaround of pharma margins
2025Superpak Karaman (TR) closed; Bangor (UK) and Leeuwarden (NL) soldFPP network pruning
21 Aug 2025H1 2025 results: Q2 EPS EUR 7.25, including the TANN gainReported profit inflated by one-off
H2 2025Removed from the ATX index; added to the S&P Global BMILower domestic index demand
4 Nov 2025Q3 2025 results: sales EUR 949.5 m, adjusted operating profit EUR 35.2 m (3.7% margin). B&P adjusted operating loss EUR 11.0 m. Shares fell about 9.8% to EUR 70.80 the following week.Board weakness resurfaces
Nov 2025Shares hit 52-week low of about EUR 69.90–70.20Sentiment trough
23 Dec 2025Buyback concluded: 569,019 shares, EUR 41.2 mCapital return
10 Feb 2026Shares reach 52-week high of about EUR 101Recovery on self-help narrative
17 Mar 2026FY2025 results: adjusted EBITDA EUR 418.2 m; net profit EUR 77.0 m; Kolicevo impairment EUR 70.5 m; Fit-For-Future target over EUR 250 m; DPS EUR 2.00; new payout policyReset of targets and capital-return policy
17 Mar 2026Warning on Middle East developments: two FPP plants (about 2% of sales, about 6% of adjusted EBITDA); interruptions expectedGeopolitical risk materialises
Mar 2026 onwardsMiddle East escalation drives significant cost pressure in energy, transport and chemicalsEarnings risk for FY2026
8 Apr 2026Annual Report 2025 publishedPrimary filing
28 Apr 2026Q1 2026 trading statement (new format): sales EUR 927.5 m; adjusted operating profit EUR 49.1 m; earnings held at prior-year level pro forma; "earnings risks" flaggedResilience despite cost shock
29 Apr 202632nd AGM approves EUR 2.00 dividend; ex-dividend 6 May 2026Dividend raised 11%
Jun 2026Shares at year-to-date low of about EUR 74.80–74.90Sentiment hit by cost inflation
17 Aug 2026Agreement to acquire R.D.M. Arnsberg operations (230 kt)First bolt-on since 2022; recycled-board consolidation
20 Aug 2026H1 2026 results: adjusted EBITDA EUR 200.2 m; PHP +14%; B&P -19%; Fit-For-Future target raised to more than EUR 330 mProgramme beating plan
27 Aug 2026Koppitz and Loimayr appointed to the Management Board from 1 Sep 2026Governance broadened
31 Aug 2026EcoVadis Platinum (91/100), up from Gold in 2025 and Silver in 2024ESG differentiation
~1 Oct 2026German competition authority reportedly clears the Arnsberg dealClosing path for Q4 2026 (S19; unconfirmed by MM)
Q3 2026Annual maintenance standstills at Kwidzyn and Kotkamills (about EUR 35 m Q3 impact)Seasonal earnings drag
Oct 2026Romania FPP expansion begins commercial production (planned)Capacity for new contracts
Autumn 2026Kwidzyn digester and efficiency projects due for completionAbout EUR 30 m a year of benefit from 2027
5 Nov 2026 (scheduled)Q3 2026 trading statementNext catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2024–FY2025): Food & Premium Packaging sales fell from EUR 1,702.4 Mn in FY2024 to EUR 1,538.4 Mn in FY2025.
Mayr-melnhof Karton AG — Revenue by Segment (FY2024–FY2025)
Series (EUR Mn)FY2024FY2025
Food & Premium Packaging sales1,702.41,538.4
Food & Premium Packaging excl. TANN sales1,488.71,449.7
Pharma & Healthcare Packaging sales615.7618.3
Board & Paper sales1,954.31,930.2
Group consolidated sales4,079.63,885.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.